N-[4-[[2-morpholin-4-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purin-6-yl]amino]phenyl]acetamide
C25H24F3N7O2 — CID 117086112
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[[2-morpholin-4-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purin-6-yl]amino]phenyl]acetamide
N-[4-[[2-morpholin-4-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purin-6-yl]amino]phenyl]acetamide (PubChem CID 117086112) has the molecular formula C25H24F3N7O2 and a molecular weight of 511.51 g/mol. Its IUPAC name is N-[4-[[2-morpholin-4-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purin-6-yl]amino]phenyl]acetamide.
Molecular Properties
| Compound Name | N-[4-[[2-morpholin-4-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purin-6-yl]amino]phenyl]acetamide |
|---|---|
| PubChem CID | 117086112 |
| Molecular Formula | C25H24F3N7O2 |
| Molecular Weight | 511.51 g/mol |
| Exact Mass | 511.19 |
| IUPAC Name | N-[4-[[2-morpholin-4-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purin-6-yl]amino]phenyl]acetamide |
| SMILES | CC(=O)Nc1ccc(Nc2nc(N3CCOCC3)nc3c2ncn3Cc2ccc(C(F)(F)F)cc2)cc1 |
| InChI | InChI=1S/C25H24F3N7O2/c1-16(36)30-19-6-8-20(9-7-19)31-22-21-23(33-24(32-22)34-10-12-37-13-11-34)35(15-29-21)14-17-2-4-18(5-3-17)25(26,27)28/h2-9,15H,10-14H2,1H3,(H,30,36)(H,31,32,33) |
| InChIKey | NYBFRZBAOHTRIS-UHFFFAOYSA-N |
| XLogP | 4.43 |
| TPSA | 97.20 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 511.51 |
| LogP ≤ 5 | 4.43 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117086112 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.